01 Advancements in Technology with the Introduction of Next-Generation Chromatography Resins Advancements in technology continue to reshape the global chromatography resin market, with next-generation resins offering improved selectivity, stability, and faster processing times. These innovations are increasingly tailored for high-throughput and automated workflows, particularly in pharmaceutical and biopharmaceutical applications. A study published in April 2024 introduced an AI-driven platform that uses predictive models to forecast critical separation parameters in chromatography. By analyzing experimental data, the platform enhances efficiency, reduces trial-and-error, and improves reproducibility in chemical purification, offering a scalable and intelligent solution for modern chromatographic workflows. This integration of AI with advanced resin technologies is expected to streamline complex separations, cut development time, and expand the adoption of chromatography in both R&D and large-scale production environments.
May 2026 Cytiva expanded its chromatography resin manufacturing capacity to support the growing demand for bioprocessing materials used in the production of monoclonal antibodies, vaccines, and cell and gene therapies.
March 2026 Purolite, an Ecolab company, introduced a next-generation Protein A chromatography resin designed to improve purification efficiency and reduce manufacturing costs for biopharmaceutical producers.
December 2025 Repligen Corporation launched a new high-capacity affinity chromatography resin to enhance downstream bioprocessing productivity and support large-scale biologics manufacturing.
July 2025 Tosoh Bioscience expanded its chromatography media portfolio with advanced ion-exchange and hydrophobic interaction resins to improve purification performance in biopharmaceutical applications.